Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -7.25%-38.01M | -10.29%-11.95M | 21.95%-6.78M | -44.77%-12.29M | 5.95%-6.99M | 4.46%-35.44M | 9.04%-10.83M | -3.29%-8.69M | 20.46%-8.49M | -21.81%-7.43M |
Net income from continuing operations | -42.02%-101.88M | -96.82%-32.27M | 41.39%-13.61M | -54.66%-24.39M | -93.35%-31.61M | -78.82%-71.74M | -31.15%-16.4M | -23.97%-23.22M | -2,006.89%-15.77M | -68.36%-16.35M |
Operating gains losses | 766.63%32.46M | 333.63%13.34M | -136.46%-2.37M | 9,471.26%8.33M | 358.59%13.17M | 115.28%3.75M | -279.65%-5.71M | 471.50%6.5M | 100.49%87K | 144.95%2.87M |
Depreciation and amortization | 8.65%5.24M | 3.96%1.31M | 4.54%1.31M | 9.85%1.29M | 17.24%1.32M | 31.33%4.82M | 24.46%1.26M | 40.97%1.26M | 33.26%1.18M | 27.55%1.13M |
Other non cash items | 64.25%5.28M | 109.61%2.92M | -4.05%1.26M | -171.08%-354K | 9,620.00%1.46M | 5,644.64%3.22M | 9,200.00%1.4M | 8,626.67%1.31M | 3,457.14%498K | 25.00%15K |
Change In working capital | 162.96%7.03M | 108.98%52K | 216.57%3.36M | -171.88%-823K | 324.69%4.44M | 199.37%2.67M | 88.04%-579K | -35.28%1.06M | 181.67%1.15M | -45.35%1.05M |
-Change in receivables | -490.85%-969K | -363.21%-1.07M | 101.43%13K | -17.32%-752K | -14.61%836K | 61.68%-164K | 155.79%405K | -92.57%-907K | 31.44%-641K | -42.55%979K |
-Change in payables and accrued expense | 413.68%6.46M | 200.64%786K | 127.05%2.55M | -188.45%-781K | 12,480.65%3.9M | 162.38%1.26M | 73.89%-781K | -29.04%1.12M | 183.94%883K | -93.02%31K |
-Change in other current assets | -24.09%498K | 125.07%169K | -40.33%358K | -31.64%512K | -2,747.37%-541K | -13.00%656K | 48.55%-674K | 66.20%600K | -18.41%749K | -102.42%-19K |
-Change in other working capital | 12.88%1.04M | -65.39%163K | 79.18%439K | 28.57%198K | 350.00%243K | 192.31%924K | 153.23%471K | 46.71%245K | 146.25%154K | 105.29%54K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -7.25%-38.01M | -10.29%-11.95M | 21.95%-6.78M | -44.77%-12.29M | 5.95%-6.99M | 4.46%-35.44M | 9.04%-10.83M | -3.29%-8.69M | 20.46%-8.49M | -21.81%-7.43M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -3,774.77%-39.47M | -949.10%-21.81M | -81.49%4.66M | 34.13%-20.21M | -152.61%-2.11M | 106.83%1.07M | 157.85%2.57M | 339.39%25.17M | -5,216.29%-30.68M | 2,030.77%4.02M |
Capital expenditure reported | 87.28%-350K | 20.00%-168K | 99.52%-1K | 89.91%-149K | 96.26%-32K | 7.19%-2.75M | 83.12%-210K | 80.85%-208K | -219.01%-1.48M | -400.58%-856K |
Net intangibles purchase and sale | 55.04%-442K | 68.00%-88K | 54.68%-92K | 39.63%-99K | 52.20%-163K | -60.36%-983K | 17.66%-275K | -58.59%-203K | -43.86%-164K | -821.62%-341K |
Net investment purchase and sale | -847.57%-35.94M | -805.83%-21.55M | -81.43%4.75M | 40.67%-17.23M | -136.79%-1.92M | 159.04%4.81M | 10,427.59%3.05M | 412.93%25.58M | ---29.03M | --5.21M |
Net other investing changes | ---2.73M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -3,774.77%-39.47M | -949.10%-21.81M | -81.49%4.66M | 34.13%-20.21M | -152.61%-2.11M | 106.83%1.07M | 157.85%2.57M | 339.39%25.17M | -5,216.29%-30.68M | 2,030.77%4.02M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -49.11%35.1M | 25,657.14%5.37M | -66.13%7.07M | -53.98%22.16M | 51,700.00%516K | 160,327.91%68.98M | -2,000.00%-21K | 695,400.00%20.86M | 218,750.00%48.15M | -104.00%-1K |
Net issuance payments of debt | -100.16%-111K | -3.57%-29K | -100.14%-27K | -100.05%-27K | -3.70%-28K | 411,217.65%69.89M | -64.71%-28K | --19.97M | --49.97M | ---27K |
Proceeds from stock option exercised by employees | 3,583.14%35.17M | 76,985.71%5.4M | 680.20%7.09M | 170,223.08%22.14M | 1,992.31%544K | 1,575.44%955K | -22.22%7K | --909K | -40.91%13K | 0.00%26K |
Net other financing activities | 102.15%40K | --0 | --0 | ---- | ---- | ---1.86M | --0 | ---23K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -49.11%35.1M | 25,657.14%5.37M | -66.13%7.07M | -53.98%22.16M | 51,700.00%516K | 160,327.91%68.98M | -2,000.00%-21K | 695,400.00%20.86M | 218,750.00%48.15M | -104.00%-1K |
Net cash flow | ||||||||||
Beginning cash position | 73.36%81.88M | -24.66%67.91M | 19.30%62.97M | 67.34%73.32M | 73.36%81.88M | -52.81%47.23M | 41.74%90.13M | -36.04%52.78M | -53.28%43.81M | -52.81%47.23M |
Current changes in cash | -222.40%-42.37M | -242.58%-28.39M | -86.77%4.94M | -215.20%-10.35M | -151.52%-8.58M | 165.58%34.62M | 49.32%-8.29M | 297.27%37.34M | 179.95%8.98M | 45.67%-3.41M |
Effect of exchange rate changes | -686.67%-176K | -690.63%-189K | -175.00%-9K | 111.11%1K | 520.00%21K | 151.72%30K | 500.00%32K | 250.00%12K | 66.67%-9K | 66.67%-5K |
End cash Position | -51.97%39.33M | -51.97%39.33M | -24.66%67.91M | 19.30%62.97M | 67.34%73.32M | 73.36%81.88M | 73.36%81.88M | 41.74%90.13M | -36.04%52.78M | -53.28%43.81M |
Free cash flow | 0.95%-38.8M | -7.83%-12.2M | 24.45%-6.87M | -23.77%-12.54M | 16.74%-7.18M | 3.68%-39.17M | 16.09%-11.32M | 5.46%-9.1M | 9.96%-10.13M | -36.78%-8.62M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |